RSE eLearning – Your Go‑to Source for Evidence‑Based Drug and Supplement Info

Looking for clear, trustworthy details on a medication, a health condition, or a dietary supplement? You’re in the right place. We break down complex science into bite‑size facts so you can make confident decisions fast.

What We Offer

Our library includes drug monographs, disease overviews, supplement efficacy reviews, and the latest treatment guidelines. Each article shows uses, dosing, safety warnings, drug interactions, and practical tips—all backed by peer‑reviewed research.

Why Trust Us

We follow a strict editorial process: every claim is checked against current studies, and all content is written by clinicians or qualified writers. Whether you’re a doctor, a health‑science student, or just curious about your own care, you’ll find reliable, up‑to‑date information without the jargon.

Explore categories like Skin Care, Cardiology, Nutrition, and Supplements & Herbal Remedies. Dive into popular guides such as Elidel cream, Nizoral shampoo, or Prasugrel after a heart attack. Ready to start learning? Browse the topics you need and get the facts you can trust.

Pregnancy and Lactation Labeling Rule (PLLR): How to Read FDA Drug Safety Info
  • Dec, 7 2025
  • Comments 0

Pregnancy and Lactation Labeling Rule (PLLR): How to Read FDA Drug Safety Info

The FDA's Pregnancy and Lactation Labeling Rule (PLLR) replaced outdated letter categories with clear, evidence-based safety info for pregnant and breastfeeding women. Learn how to read the new labels and make informed medication decisions.
Read More  
What Are Drug Side Effects: Definition, Causes, and Real-World Examples
  • Dec, 6 2025
  • Comments 2

What Are Drug Side Effects: Definition, Causes, and Real-World Examples

Learn what drug side effects really are, why they happen, and how common they are - with real examples, causes, and practical tips for managing them safely. Understand the difference between minor and serious reactions.
Read More  
The 80-125% Rule: Understanding Bioequivalence Confidence Intervals for Generic Drugs
  • Dec, 5 2025
  • Comments 2

The 80-125% Rule: Understanding Bioequivalence Confidence Intervals for Generic Drugs

The 80-125% rule ensures generic drugs are absorbed the same way as brand-name versions. Learn how bioequivalence confidence intervals work, why they matter, and what the data really says about generic safety.
Read More  
Biologic Patent Protection: When Biosimilars Can Enter the U.S. Market
  • Dec, 4 2025
  • Comments 2

Biologic Patent Protection: When Biosimilars Can Enter the U.S. Market

Biologic drugs in the U.S. enjoy 12 years of market exclusivity before biosimilars can enter, thanks to FDA rules and patent thickets. This delays competition, keeps prices high, and leaves patients paying more than those in other countries.
Read More  
Bursitis and Tendinitis: How to Tell Them Apart and Treat Them Right
  • Dec, 4 2025
  • Comments 4

Bursitis and Tendinitis: How to Tell Them Apart and Treat Them Right

Bursitis and tendinitis cause joint pain but affect different tissues. Learn how to tell them apart, what treatments actually work, and why misdiagnosis delays recovery by weeks.
Read More  
Autoimmune Overlap: Understanding PBC, PSC, and AIH Combined Features
  • Dec, 4 2025
  • Comments 2

Autoimmune Overlap: Understanding PBC, PSC, and AIH Combined Features

Autoimmune overlap syndromes combine features of PBC, PSC, and AIH, requiring specialized diagnosis and dual treatment. Learn how to spot the signs and why standard therapies often fail.
Read More  
Creatine and Kidney Disease Medications: How to Monitor Renal Function Safely
  • Dec, 3 2025
  • Comments 2

Creatine and Kidney Disease Medications: How to Monitor Renal Function Safely

Creatine can falsely raise creatinine levels, leading to misdiagnosis of kidney disease. Learn how to monitor kidney function safely if you're on kidney meds or have CKD - without stopping your supplement.
Read More  
Patient Communication in Drug Shortages: What Providers Must Do
  • Dec, 1 2025
  • Comments 5

Patient Communication in Drug Shortages: What Providers Must Do

When drugs run short, providers must communicate clearly, honestly, and empathetically. Learn what patients need to hear, how to explain alternatives, and why failing to act can break trust-and risk safety.
Read More  
Chinese Generic Production: Manufacturing and Quality Concerns in Global Pharma
  • Dec, 1 2025
  • Comments 5

Chinese Generic Production: Manufacturing and Quality Concerns in Global Pharma

Chinese manufacturers produce 80% of the world's generic drug ingredients, offering low prices but raising serious quality concerns. Learn how supply chain risks, regulatory gaps, and inconsistent safety standards affect the medicines you take.
Read More  
Provider Education: Understanding Biosimilar Differences
  • Dec, 1 2025
  • Comments 7

Provider Education: Understanding Biosimilar Differences

Biosimilars are not generics. They're complex biological drugs that require special understanding. Learn how they differ, why provider education matters, and how to confidently use them in practice.
Read More  
Hemochromatosis: How Iron Overload Damages Your Liver and How Phlebotomy Fixes It
  • Nov, 29 2025
  • Comments 9

Hemochromatosis: How Iron Overload Damages Your Liver and How Phlebotomy Fixes It

Hemochromatosis is a common genetic disorder that causes dangerous iron buildup, especially in the liver. Phlebotomy - regular blood removal - is the proven, low-cost treatment that can prevent cirrhosis, diabetes, and liver cancer if started early.
Read More  
Regulatory Exclusivity: How Non-Patent Protections Delay Generic Drugs
  • Nov, 28 2025
  • Comments 7

Regulatory Exclusivity: How Non-Patent Protections Delay Generic Drugs

Regulatory exclusivity is a government-granted market protection that delays generic drug approval, independent of patents. It gives drugmakers 5 to 12 years of exclusive sales rights and plays a major role in high drug prices.
Read More